News for Atento S.A. (ATTO)

The global outbound telemarketing market is expected to grow at a significant CAGR during the forecast period. Outbound Telemarketing is a marketing technique to develop new customers/clients and…

CORRECTED-U.S. TRADE REPRESENTATIVE REQUESTS USMCA PANEL ON LABOR DISPUTE AT FACILITY OPERATED BY ATENTO SERVICIOS, S.A. DE C.V. IN PACHUCA DE SOTO, HIDALGO -APRIL 16 STATEMENT ...

Atento appoints Álvaro Badiola Guerra as Group CFO · His appointment as Chief Financial Officer will drive forward the...

Atento S.A. Société Anonyme 1 rue Hildegard Von Bingen L-1282 Luxembourg R.C.S. Luxembourg B.185.761 27 September 2023 By ordinary mail Dear Shareholder: We are delighted to inform you...

Atento S.A. , one of the world's largest customer relationship management and business process outsourcing service providers and an industry leader in Latin America, announced that,...

Atento receives backstop commitments for an additional $76 million in exit financing. This additional funding commitment comes on top of the $37 million...

PUNE, Oct. 03, 2023 (GLOBE NEWSWIRE) --

/PRNewswire/ -- Atento S.A. (

Atento S.A. Draws Down $17M in Trance 2 Funding

Delisting is contemplated by the previously announced comprehensive financial restructuring plan aimed at optimizing financial and operational efficiency and driving long-term growth. Delisting...

The massacre, stock by stock, all 1001 of them, listed right here.

Pune, Oct. 12, 2022 (GLOBE NEWSWIRE) -- "Outbound Telemarketing Market" estimated at US$ 10830 million in the year 2022, is projected to reach a revised...

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.

Read Stock Analysts’ Upgrades for June 1st (APLT, ARHS, ASTS, ATHX, ATNM, ATTO, AURA, AVDX, BAK, BBLN) at ETF Daily News

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.